Trial Profile
A double blind study of KRN125 compared to placebo for chemotherapy-induced neutropenia in breast cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Jun 2016
Price :
$35
*
At a glance
- Drugs Pegfilgrastim (Primary)
- Indications Neutropenia
- Focus Therapeutic Use
- Sponsors Kyowa Hakko Kirin
- 03 Jun 2016 New trial record